Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Sorenson Capital
company
About
Growth equity firm that backs high-growth B2B software companies from Series B to pre-IPO
- 11 - 50
Highlights
Details
- Industries
- Financial Services,Venture Capital
- Founded date
- Jan 1, 2002
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Investor Type
- PE,Venture Capital
Sorenson Capital is a growth equity firm that backs market-defining B2B software companies. Through two decades of partnering with high-performing entrepreneurs, Sorenson Capital has developed a repeatable playbook to help companies build their go-to-market efforts to achieve lasting scale. The firm’s strategy is to invest in minority positions in high-growth companies from the Series B to pre-IPO stage.
Investments
Number of Investments
Number of Lead Investments
11
3
Sorenson Capital has made 11 investments. Their most recent investment was on
Dec 5, 2022, when Expeto raised $12M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Dec 5, 2022
Expeto
|
Series B | $12M | Information Services | Yes |
|
May 31, 2022
Vendia
|
Series B | $30M | Blockchain | — |
|
Apr 11, 2022
Tive
|
Series B | $54M | Enterprise Software | — |
|
May 25, 2021
Qualio
|
Series B | $50M | Biotechnology | — |
|
Jul 16, 2020
Qualio
|
Series A | $11M | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
